Latest news with #AxsomeTherapeuticsInc
San Francisco Chronicle
6 days ago
- Business
- San Francisco Chronicle
Axsome: Q2 Earnings Snapshot
NEW YORK (AP) — NEW YORK (AP) — Axsome Therapeutics Inc. (AXSM) on Monday reported a loss of $48 million in its second quarter. On a per-share basis, the New York-based company said it had a loss of 97 cents. Losses, adjusted for one-time gains and costs, came to 92 cents per share. The results topped Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of $1 per share. The biopharmaceutical company posted revenue of $150 million in the period, also topping Street forecasts. Ten analysts surveyed by Zacks expected $139.6 million. Axsome shares have climbed 22% since the beginning of the year. The stock has increased 22% in the last 12 months. _____
San Francisco Chronicle
05-05-2025
- Business
- San Francisco Chronicle
Axsome: Q1 Earnings Snapshot
NEW YORK (AP) — NEW YORK (AP) — Axsome Therapeutics Inc. (AXSM) on Monday reported a loss of $59.4 million in its first quarter. The New York-based company said it had a loss of $1.22 per share. Losses, adjusted for non-recurring costs, came to 80 cents per share. The results exceeded Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of $1.26 per share. The biopharmaceutical company posted revenue of $121.5 million in the period, which also topped Street forecasts. Eight analysts surveyed by Zacks expected $119.5 million. Axsome shares have risen 33% since the beginning of the year. The stock has increased 50% in the last 12 months. _____
